Note: Ingredients listed on restricted chemical lists
EC/CAS
215-687-4/1344-09-8
Name of the chemical
Silicic acid, sodium salt
Concentration
31-0016
General Information
Version
GHS 7.0
Revision date
2024-04-03
Product name
Crystal Activator
REACH No
not
1.2.1 Relevant identified uses
Primer
Emergency telephone
+43 (0)1 4064 343-0
Icons in SDS
Company Information
company name
Baumit GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
office@baumit.com
GHS Information
Signal word
danger
Hazard Codes
Hazard statements (CLP)
H314
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.2 skin corrosion/irritation 1C Skin Corr. 1C H314 For full text of abbreviations: see SECTION 16.
Most important adverse effects
Skin corrosion produces an irreversible damage to the skin; namely, visible necrosis through the epi- dermis and into the dermis.
2.2 Label elements
Labelling
Signal word
danger
Hazard pictograms
GHS05
Hazard statements
H314 Causes severe skin burns and eye damage.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P103 Read carefully and follow all instructions. P260 Do not breathe spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P330+P331 IF SWALLOWED: rinse mouth. Do NOT induce vomiting. P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER/doctor. P501 Dispose of contents/container in accordance with local/regional/national/inter- national regulations.
Supplemental label elements
EUH210 Safety data sheet available on request.
Results of PBT and vPvB assessment
Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
